Gonadal function is associated with cardiometabolic health in pre-pubertal boys with Klinefelter syndrome

Andrology. 2016 Nov;4(6):1169-1177. doi: 10.1111/andr.12275. Epub 2016 Sep 16.

Abstract

The most common sex chromosome aneuploidy, Klinefelter syndrome (KS), is associated with primary gonadal failure and increased morbidity and mortality from cardiometabolic disorders in adulthood. Children with KS also have a high prevalence of metabolic syndrome (MetS) features. To assess the relationship of gonadal and cardiometabolic function in children with KS, we evaluated serum hormones [gonadotropins, inhibin B (INHB), anti-mullerian hormone (AMH), total testosterone (TT)], and features of MetS (waist circumference, fasting lipid panel, fasting blood glucose (FBG), and blood pressure) in 93 pre-pubertal boys with KS age 4-12 years (mean 7.7 ± 2.5 years). The cohort was grouped by age and tanner stage, and biomarkers were compared to normal ranges. A total of 80% of this pre-pubertal cohort had ≥1 feature of metabolic syndrome (MetS) and 11% had ≥3 features of MetS. Risk of MetS was independent of age and body mass index. Sertoli cell dysfunction was common with 18% having an INHB below the normal range. A low INHB was associated with higher FBG, triglycerides, LDL, and lower HDL (p < 0.05). An INHB <50 ng/dL yielded a sensitivity of 83% and a specificity of 79% for having ≥3 features of MetS. INHB and AMH positively correlated with each other (p < 0.001), and high AMH was protective of MetS. TT was below the lower limit of normal in 49% of subjects, with mean values significantly lower than expected (3.3 ng/dL vs. 4.9 ng/dL, p < 0.0001), however, no convincing relationship between TT and MetS was seen. In conclusion, gonadal and cardiometabolic dysfunction are prevalent in pre-pubertal boys with KS. Although the relationship of testosterone deficiency and MetS is well-known, this study is the first to report an association between impaired Sertoli cell function and cardiometabolic risk.

Trial registration: ClinicalTrials.gov NCT00348946.

Keywords: 47,XXY; Klinefelter syndrome; anti-mullerian hormone; cardiometabolic; gonadal function; hypogonadism; inhibin B; metabolic syndrome; sex chromosome aneuploidy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Mullerian Hormone / blood
  • Blood Glucose / metabolism*
  • Blood Pressure / physiology*
  • Child
  • Child, Preschool
  • Follicle Stimulating Hormone / blood
  • Humans
  • Hypogonadism / blood
  • Hypogonadism / physiopathology*
  • Inhibins / blood
  • Klinefelter Syndrome / blood
  • Klinefelter Syndrome / physiopathology*
  • Luteinizing Hormone / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / physiopathology
  • Sertoli Cells / metabolism
  • Testosterone / blood*
  • Triglycerides / blood
  • Waist Circumference / physiology*

Substances

  • Blood Glucose
  • Triglycerides
  • inhibin B
  • Testosterone
  • Inhibins
  • Anti-Mullerian Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone

Associated data

  • ClinicalTrials.gov/NCT00348946